1. Outcomes Associated With Paroxysmal Supraventricular Tachycardia During Pregnancy
- Author
-
Chang-Fu Kuo, Weiya Zhang, Ming-Shien Wen, I-Jun Chou, Lai-Chu See, Meng-Jiun Chiou, Kuang-Hui Yu, Shue-Fen Luo, Shang-Hung Chang, Wei-Jan Chen, Yung-Hsin Yeh, and Michael Doherty
- Subjects
Pregnancy ,Pediatrics ,medicine.medical_specialty ,Heart disease ,business.industry ,Birth weight ,medicine.medical_treatment ,Gestational age ,Catheter ablation ,030204 cardiovascular system & hematology ,Institutional review board ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Informed consent ,Physiology (medical) ,medicine ,Apgar score ,Cardiology and Cardiovascular Medicine ,business ,030217 neurology & neurosurgery - Abstract
Editorial, see p 590 Paroxysmal supraventricular tachycardia (PSVT) is the most common symptomatic arrhythmia during pregnancy.1 Although PSVT is usually considered transient and harmless, its association with maternal and fetal outcomes during pregnancy are unknown.2–4 In this study, we used a national population cohort to measure the associations between PSVT events during pregnancy and maternal or fetal outcomes and to evaluate the associations between prior ablation of PSVT and those outcomes. This study was approved by the Institutional Review Board of Chang Gung Memorial Hospital, Taiwan. We obtained records of all pregnancies in Taiwan between 2001 and 2012 from a national insurance database. Gestational age, birth weight, Apgar score, and fetal outcomes were obtained from Taiwan’s national birth registry to which obstetricians are required by law to report fetal and maternal information. Mothers who were 44 years of age or who had had congenital heart disease, a gap between deliveries that was 20 years, or multiparities were excluded. Informed consent was waived because of anonymous data. Symptomatic PSVT was defined as …
- Published
- 2017